免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Zephyr Valve Japan Post-Marketing Surveillance

NCT:NCT06332885 · RECRUITING

NCT编号NCT06332885
状态RECRUITING
开始日期2024-03-12
完成时间2028-03-31
SponsorPulmonx Corporation (INDUSTRY)
First posted
Last updated

简要摘要

This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20 centers across Japan and followed for 12 months.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑